Detail Study on Autoinjectors Market is Projected to Grow Magnificent CAGR till 2024

 Autoinjectors Market Overview

Global Autoinjectors Market growth is expected to register a CAGR of 17.42% to reach USD 79,741 Million by 2024.

Autoinjectors are medical devices designed to deliver the dose of the drug. These are easy to use and are intended for self-administration by patients and physicians.

Autoinjectors have numerous advantages such as decreased needle phobia anxiety and maintain dose accuracy which in turn help in the growth of the market. The growing prevalence of targeted therapies, rising incidence of anaphylaxis, and the increasing number of regulatory approvals are factors responsible for market growth.  

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6311

Market Dynamics

The global autoinjectors market has been largely benefited by the rising incidence of anaphylaxis and the growing prevalence of targeted therapies. However, increased product recall and stringent regulatory policies are anticipated to restrain market growth.

Autoinjectors Market Segmentation

The disposable autoinjectors segment is expected to lead the market and register a substantial CAGR to reach USD 53,696.20 Million by the end of 2024. The increasing demand for testing new drugs and chemicals and vigorous growth in the pharmaceutical and biopharmaceutical sectors are expected to drive the market growth. Additionally, the disposable autoinjectors segment is also projected to exhibit the highest CAGR of 17.90% from 2019 to 2024.

Autoinjectors Market Key Players

The prominent players in the global autoinjectors market are Amgen Inc. (US), Becton, Dickinson and Company (US), AbbVie Inc. (US), Mylan N.V. (US), Eli Lilly and Company (US), Ypsomed (Switzerland), Owen Mumford Ltd (UK), Consort Medical (UK), SHL Group (Taiwan), Johnson & Johnson Services Inc. (US), Teva Pharmaceutical Industries Ltd (Israel) and Antares Pharma (US).

The players operating in the global autoinjectors market are focusing on product launches, along with expanding their global footprints by entering untapped markets.   

Americas accounted for the largest market share of 40.6% in 2018, and the regional market is projected to register a CAGR of 16.60% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Indian market is projected to exhibit the highest growth rate of 18.95% during the forecast period of 2019 to 2024. 

The European market is estimated to exceed USD 24,307.74 million by 2024. The well-established healthcare infrastructure, technology advancement, and innovation in drug delivery systems, and rising prevalence of anaphylaxis incidences, diabetes, and cancer are the factors driving the growth of the autoinjectors market in the region. Germany is the major contributor to the growth of the regional market, followed by France.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/autoinjectors-market-6311

Hyperspectral Imaging System Market Estimated to Witness a Vigorous Growth by 2027

 Market Highlights

Global COVID-19 Diagnostics Market report is expected to register a CAGR of 6.28% during the forecast period, with a market value of USD 96,293.9 Million by 2027. COVID-19 is one of the most harmful infectious diseases that is caused by a coronavirus. Wuhan, China was the first place to experience the disease’s outbreak, followed by Europe, and then to the other countries globally by infected people.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/9710 

Segment Analysis

Global COVID-19 Diagnostics Market has been segmented by Type, Technology, and End Users. The market, based on type, has been bifurcated into molecular tests and serology tests. On the basis of technology, the market has been bifurcated into RT-PCR, isothermal amplification, CRISPR, ELISA, hybridization, and others.

Based on End User, the COVID-19 diagnostics market has been segregated into hospitals, public health labs, private or commercial labs, and others.

Regional Analysis

Global COVID-19 Diagnostics Market, based on region, has been divided into the Europe, Americas, Asia-Pacific, and the Middle East & Africa.

The Europe is likely to dominate the global COVID-19 diagnostics market. This can be attributed to the high COVID-19 morbidity and mortality observed among residents in long-term care facilities (LTCF) in European Union (EU) and European Economic Area (EEA) pose a major challenge for disease prevention and control in such settings, which raises the demand for the wide availability of diagnostics for immediate detection of COVID-19 cases. According to European Centre for Disease Control and Prevention, 157 312 deaths in the EU/EEA and the UK as of 19 May 2020 were reported. Moreover, the support from public & private organizations in tackling COVID-19 is also expected to drive market growth in the region.

The American market for COVID-19 diagnostics is expected to be the second largest during the forecast period. Rising product launches by major players and ongoing public and private organizations’ efforts to control the spread of the virus is anticipated to drive the market growth. For instance, in March 2020, the US FDA issued a EUA for a molecular point of care test kit by Abbott for the rapid detection of COVID-19. Furthermore, the increasing numbers of corona virus-positive cases also act as a driving factor and support market growth.

Asia-Pacific is estimated to be the fastest-growing market. With an increasing number of cases, governments across the Asia-Pacific countries are exploring the opportunities of allowing private laboratories to ramp up testing, which is boosting the market growth. For instance, In India, the Indian Council of Medical Research (ICMR) has approved 51 private laboratories for COVID-19 testing on March 31, 2020. Moreover, the increasing number of COVID-19 cases is also driving the market growth.

The market in the Middle East & Africa is expected to witness steady growth. Countries such as Kuwait, the UAE, and Saudi Arabia are likely to show steady growth due to increasing COVID-19 cases and rising initiatives by governments to improve patient care.Key Players

MRFR recognizes the following companies as the Key Players in the Global COVID-19 Diagnostics Market— Becton, Dickinson & Company (US), Bio-Rad Laboratories (US), Danaher Corporation (US), Abbott (US), F. Hoffmann-La Roche Ltd (Switzerland), Biomerieux SA (France), Genmark Diagnostics (US), Thermo Fisher Scientific (US), Qiagen (Germany), and Siemens AG (Germany).

Key Findings of the Study

• Global COVID-19 Diagnostics Market is estimated to reach USD 96,293.86 million by 2027 at a CAGR of 6.28% during the assessment period
• The Europe accounted for the largest share of the global COVID-19 diagnostics market due to the increasing number of COVID-19 cases
• Based on type, the molecular tests segment accounted for the largest market share of 58.3% in 2020
• On the basis of technology, the RT-PCR segment accounted for the largest market share of 25.4% in 2020
• On the basis of end user, the hospitals segment accounted for the largest market share of 33.6% in 2020

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/covid-19-diagnostics-market-9710

Whole Exome Sequencing Market Poised to Witness a Significant Growth by 2025

 Whole Exome Sequencing Market Overview

As per Market Research Future (MRFR) analysis, the global whole exome sequencing market research, market is estimated to reach USD 2,696.03 million with a CAGR of 19.80% from 2019 to 2025 (forecast period).

Whole exome sequencing is a broadly used next-generation sequencing (NGS) method to determine the nucleotide sequence primarily of protein-coding regions of individual-related sequences, reflecting approximately 1% of the complete DNA sequence. Human exome accounts for less than 2% of the genome but contains -85% of known disease-related variants. This is the primary explanation for the use of exome in the detection and determination of genetic variants that cause different diseases, such as Miller syndrome and Alzheimer’s. 

Get a FREE Sample (Including COVID19 Impact Analysis, Full TOC, Tables and Figures) of Whole Exome Sequencing Market @ https://www.marketresearchfuture.com/sample_request/8763

Whole Exome Sequencing Market Dynamics

Factors driving market growth include decreasing sequencing costs, the use of whole exome sequencing technology for a variety of applications, and strategic alliances between key players and research institutes. 

Moreover, market players are operating in the global exome sequencing market emphasis on product launches, approvals, and collaborations to gain market dominance and keep their product updated and in demand. For example, in November 2019, NantHealth, Inc. (US), a next-generation, personalized healthcare company, received FDA approval from Omics CoreSM, the first whole exome sequencer used to examine both tumor and somatic genes to determine the overall tumor mutation burden (TMB) in cancer tissue.

However, the lack of qualified professionals and ethical and legal concerns related to whole exome sequencing are hindering the growth of the industry. 

Whole Exome Sequencing Market Segmentation

The global market for whole exome sequencing market has been segmented based on the product, technology, application, and end-user. 

Based on the product, the global market for whole exome sequencing has been segmented into kits, sequencer, and services. Kits are further divided into DNA Fragmentation, A-Tailing, End Repair, Size Selection Kits, Target Enrichment, and Library Preparation. Services are further sub-segmented into Data Analysis (Bioinformatics), Sequencing Services, and Others. 

Based on technology, the global market for whole exome sequencing has been classified as Sequencing by Synthesis (SBS), ION Semiconductor Sequencing, and others. 

Based on application, the global market for whole exome sequencing has been segmented into diagnostics, drug discovery, development, agriculture, animal research, and others.

Based on end-user, the global market for whole exome sequencing has been segmented into research centers, government institutes, hospitals and diagnostics centers, pharmaceutical and biotechnology companies, and others. 

Whole Exome Sequencing Market Regional Analysis

The global market for whole exome sequencing is segmented into the Americas, Europe, the Asia Pacific, and the Middle East & Africa.

The Americas were the biggest whole exome sequencing market in 2019. The expansion of the Americas market is due to the increasing prevalence of cancer and other chronic disorders and rising healthcare expenditure. In addition, favorable initiatives by the government and other organizations for the development and adoption of whole exome sequencing technologies are fueling the market growth for whole exome sequencing. For example, in 2018, the All Us Research Program, part of the National Institutes of Health, received more than USD 28.6 million in funding to establish three genome centers in the US.

Europe is the second-largest whole exome sequencing market in Western Europe, with the largest market share. The European market is projected to have a steady growth rate during the forecast period due to growing cancer cases and increasing genome sequencing programs. As per the International Agency for Cancer Research, there were nearly 4,229,662 cases of cancer in Europe in 2018. These huge cancer cases and increasing genome mapping programs are expected to have a significant impact on the growth of the whole exome sequencing market.

The Asia Pacific is projected to show the highest potential for market growth over the forecast period due to the rising patient pool and growing technological advancements. The rapid growth of the Asia Pacific region is due to an increase in per capita income and government initiatives to improve the quality of healthcare. China, India, and Australia have a profitable market for whole exome sequencing due to the growing elderly population.

In the Middle East & Africa, the whole exome sequencing market accounts for a substantial market share. Countries such as Kuwait, Saudi Arabia, and the UAE are expected to see steady growth due to a rise in cancer cases, increasing government efforts to enhance health care, and favorable reimbursement policies. Nevertheless, the rest of the Middle East and Africa may show inactive growth due to affordability and accessibility issues. 

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/whole-exome-sequencing-market-8763

Hyperspectral Imaging System Market Estimated to Witness a Staggering Growth by 2025

 Healthcare Personal Protection Equipment Market Analysis  

The global healthcare personal protection equipment market is likely to touch USD 10.116 billion at a 9.17% CAGR between 2019- 2027, according to the recent Market Research Future (MRFR) report. Personal Protective Equipment or PPE, simply put, are protective gears for offering protection to workers by decreasing the exposure to biological agents. Some of the components of PPE include shoe cover, coverall/gowns, gloves, mask, face shield, goggles, and others.  

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/9594

Various factors are propelling the global healthcare personal protection equipment market growth. Such factors, according to the new MRFR report, include growing demand for protective clothing, respiratory protection, and hand protection to ensure the safety of people at the time of the ongoing coronavirus pandemic, technological advances in surgery like High-Reliability Organizing, increasing initiatives by the government for increasing the imports of PPE, increasing production of integrated and cost-effective PPE, rising end user demand, and the emergence of several local PPE manufacturers.  

On the contrary, high raw material cost and inadequate supply during the COVID-19 outbreak are factors that may limit the global healthcarepersonal protection equipment market growth over the forecast period. 

Covid-19 Analysis /Covid-19 Impact on the Healthcare Personal Protection Equipment Market  

Personal Protection Equipment are helping healthcare workers in fighting against COVID-19 pandemic. The WHO has suggested governments across the world to boost the production of coverall/gowns, respirators, gloves, and masks. Besides, the PPE manufacturers have been suggested to boost their production by about 40% as well as prioritizing their orders in countries having a huge demand-supply gap. The burgeoning demand for protective clothing, respiratory protection, and hand protection in the healthcare sector to ensure the safety of people during this outbreak is predicted to increase the demand for PPE. 

Market Research Future (MRFR) collected data on several factors including implications of COVID 19 Impact on Healthcare Personal Protection Equipment Market and demographic challenges, showed how it could move forward in the coming years.

Healthcare Personal Protection Equipment Market Segmentation 

The MRFR report offers an inclusive segmental analysis of the global healthcare personal protection equipment market report based on end use and product.  

By product, the global healthcare personal protection equipment market is segmented into protective footwear, respiratory protection, face, head, and eye protection, protective clothing, hand protection, and others. Protective clothing is again segmented into gowns, coveralls, and others. Respiratory protection is again segmented into respiratory masks, surgical masks, and others. Hand protection is again segmented into sterile gloves, chemical handling, surgical, and general-purpose. Of this, respiratory protection will dominate the market over the forecast period for the increasing demand for respirators and surgical masks to protect the staff in hospitals and clinics against contaminants and pathogens. 

By end use, the global healthcare personal protection equipment market is segmented into academic and research institutes, hospitals and clinics, diagnostic laboratories, ambulatory surgical centers, and others. Of these, hospitals and clinics will have lions share over the forecast period for the rising number of physicians in emerging economies and the increasing number of people choosing medical services for treatment.  

Healthcare Personal Protection Equipment Market Regional Analysis  

Based on the region, the global healthcare personal protection equipment market report covers the recent trends & growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will have the lions share in the market over the forecast period for increasing cases of COVID-19 infection, the rising concerns about safety and health of healthcare professionals, and increasing government initiatives.  

The global healthcare personal protection equipment market in Europe is likely to possess the second-largest share during the forecast period for the increasing healthcare expenditure that is leading in increasing consumption and production of medical products and devices.  

The global healthcare personal protection equipment market in the APAC region is predicted to grow at a fast rate over the forecast period. Factors fuelling market growth include a high target population, increasing focus of government towards healthcare facilities, and technological advances.  

The global healthcare personal protection equipment market in the MEA is predicted to have sound growth over the forecast period for the increasing penetration of personal protective equipment in South Africa and the UAE.  

Healthcare Personal Protection Equipment Market Key Players 

Notable players profiled in the global healthcare personal protection equipment market report include KOWA (Japan), Med-Con (Australia), priMED Medical Products, Inc. (Canada), Halyard Health, Kimberly-Clark Worldwide, Inc. (US), Plasti Surge Industries Pvt. (India), Alpha Pro Tech (Canada), Medisca Inc. (US), Crosstex International, Inc. (US), DuPont (US), Sterimed (US), Ansell (Australia), Medtronic PLC (Ireland), Honeywell International Inc. (US), and 3M. 

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/healthcare-personal-protection-equipment-market-9594

Global Particle Counter Market Expected to Grow with a healthy CAGR

 The obsession with cleanroom technology across industrial sectors has led to the development of products able to track contaminants. Presence of contaminants can dilute solutions or send out wrong readings in sensitive environments. Particle counters are instruments which can detect and count physical particles. It can calculate the volume of particles in the air in cleanrooms and workplaces. Market Research Future (MRFR) has outlined the various factors and restraints enveloping the global particle counter market in its latest report as well as predictions for the period of 2019 to 2025 (forecast period). The pervasion of the COVID-19 and its effects are analyzed in detail in the report.

Particle Counter Market Scope

Global particle counter market size is expected to cross USD 168.2 Million by 2025 at a CAGR of 7.1% during the forecast period of 2019 to 2025.

Get a FREE Sample (Including COVID19 Impact Analysis, Full TOC, Tables and Figures) of Particle Counter Market @ https://www.marketresearchfuture.com/sample_request/8776

Production of drugs, vaccines, and other chemicals by chemicals, pharmaceuticals, and other industries can drive the need for particle counters. Strict regulations pertaining to the removal of contaminants and removal of harmful bacteria can push the market demand greatly. Investments in research and development activities can fuel market demand as well. According to the National Institute for Health Research, the Association of the British Pharmaceutical Industry (ABPI) had invested close to USD 4.46 billion in 2015.

But high costs of particle counters can limit market growth.

Particle Counter Market Competition

key players of the global particle counter market are –

• Climet Instruments Company
• Lighthouse Worldwide Solutions Inc.
• Setra Systems
• TSI Incorporated
• Met One Instruments Inc.
• Chemtrac Inc.
• Particle Measuring Systems Inc.
• Rion Co. Ltd.
• Beckman Coulter 

Particle Counter Market Segmentation

The global particle counter market is segmented by product type, modularity, technology, and end user.

By product type, it is divided into liquid and airborne particle counters. Airborne particle counters are expected to take the lead in the market till 2025. This can be attributed to its sensitivity towards dust particles and ability to monitor room contamination. On the other hand, liquid particle counters can capture a significant market share owing to application in automotive, heavy machinery, and aviation & space exploration.

By modularity, it is segmented into handheld, portable, and remote particle counters.

By technology, it is divided into offline and online particle counters. Online particle counters can hold maximum market share owing to its ability to detect particles in lubricating and hydraulic systems.

By end user, it is segmented into pharmaceutical industry, medical device industry, research laboratories, and others.

Particle Counter Market Regional Analysis

Europe, the Americas, Asia Pacific (APAC), and the Middle East & Africa (MEA) are prime regions considered in the global particle counter market.

The Americas held the largest market share in 2018. It is likely to dominate the market during the forecast period owing to adoption of particle counters and regulations enforced by federal agencies. Launch of new products by players and expansion of product portfolios can encourage market growth.

Europe is expected to induce heavy demand for the global market due to the need for particle counters in medical device and pharmaceutical industries. The large population, a spike in healthcare spending, and support from governments are primary drivers of the regional market.

APAC accounted for the third position in the market due to investments by American and European stalwarts, developments in healthcare manufacturers, large number of research organizations, low manufacturing costs, and economical labor costs.

The MEA region accounted for the lowest market share due to limited investments in modernization of healthcare infrastructure.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/particle-counter-market-8776

Hyperspectral Imaging System Market - Factors Driving Growth Post 2025

 Hyperspectral Imaging System Market Overview 

Hyperspectral imaging systems market size have drastically evolved from a broad, complicated, satellite or aviation-based remote sensing device into a reliable, lightweight, efficiently priced imaging and spectroscopic system for a variety of systems integration, diagnostic, monitoring, and inspection applications. In the life sciences, uses include colorimetry and color grading, spectral radiometry, industrial process management and quality control, live cell microscopy, pharmaceutical preparation and packing, identification of bio-agents, forensic analysis, camouflage identification, genomics and proteomics study and pre-cancer cell identification. 

Get a FREE Sample with Complete TOC By considering the COVID-19 impact on market @ https://www.marketresearchfuture.com/sample_request/8741

The use of scene assessment imaging techniques is becoming a key tool for remote, non-destructive evaluation. Traditional imagery, whether monochrome or colour, is based on the image’s spatial resolution. If the picture is distorted or too blurry thus the viewer would not be able to tell exactly what or where the object is. Hyperspectral imagery provides important details to a scene’s brightness evaluation by incorporating the amount of light from the spatial location of each image as a feature of the wavelength. 

Hyperspectral data is often handled with loads of extra bands as enhanced multispectral data — a method that is usually inefficient, and a waste of bandwidth and processing time. Methodologies are available to match spectral information curves, and also provide key sample information. The accuracy of the information obtained depends on the mechanical properties of the instrument, the requirements for lighting and the interpretation of the experimental data — all of which are also calculated by the particular specifications of an application. 

Hyperspectral Imaging System Market Segmentation 

The optical and spectral properties of a hyperspectral imaging device are essentially determined by the criteria for operation. All devices, however, have that in general the same basic elements: a means of imaging the specimen, a means of providing both spectral and spatial resolution as well as a means of detection. On the basis of the product the global market for hyperspectral imaging systems has been segmented into Short-Wave Infrared, Visible/Near-Infrared, Mid-Wave Infrared, and Long-Wave Infrared. And based on application the market has been segmented into Remote Sensing, Surveillance, and Medical Diagnostics, and Machine Vision/Optical vision. Based on the technology, the market has been segmented into Pushbroom, Snapshot, and others. 

Hyperspectral Imaging System Market Regional Overview 

Americas is projected to become the largest global market, due to the involvement of leading players in America’s major countries. The European region has the second largest market share, as regulatory bodies are gradually endorsing initiatives for cancer control. The region Asia-Pacific is projected to become the fastest-growing region in the worldwide market for hyperspectral imaging systems. This area is experiencing a boom in developing nations such as India due to rising mining activities, and increasing biotech and agriculture industries. Owing to a poor health system and insufficient access to novel technologies, the smallest regional market is the Middle East & Africa.

Hyperspectral Imaging System Industry News 

The multimodal Raman microscope LabRAM Soleil is designed for imaging with UV-VIS-NIR. The confocal imaging microscope deals with ultrafast images, innovative features of processing and a set of applications. An picture-compression algorithm allows for fast hyperspectral imaging, and up to 6 lasers and 6 spectroscopic modules can be used.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/whole-exome-sequencing-market-8763

Global Digital 3D Printing Market Racing to a Heightened Growth by 2025

 Market Analysis 

Thedigital 3D printing market overview by MRFR says market is likely to touch USD 5,214.8 million at a 20.54% CAGR between 2019-2025, reveals the new Market Research Future (MRFR) report. Digital 3D printing, simply put, is a printing process that includes the evaluation as well as improvement of products & services in a systematic way to attain better quality. It is associated with those that manage the delivery of healthcare services and includes three vital steps- measurement, assessment, & improvement. 

Numerous factors are adding to the digital 3D printing market demand. Such factors, as revealed by the latest MRFR report, include increasing applications in the healthcare industry, technological advancements, increasing public-private funding, speedy process, ability to develop customized products, and reduction of errors. 

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8680

On the contrary, the shortage of skilled labors, and high cost are factors that may limit the digital 3D printing market growth over the forecast period. 

Market Segmentation 

The Market Research Future Report provides an inclusive segmental analysis of the digital 3D printing market based on end user, application, technology, material, and component. 

By component, the digital 3D printing market is segmented into software/services and system/device. Of these, the system/device segment will lead the market over the forecast period. 

By material, the digital 3D printing market is segmented into ceramics, metal and alloy, polymers, and others. Of these, polymers will dominate the market over the forecast period. 

By technology, the digital 3D printing market is segmented into electron beam melting, jetting technology, laser sintering, deposition modeling, stereolithography, and others. Of these, stereolithography will have a major share in the market over the forecast period. 

By application, the digital 3D printing market is segmented into drug screening, hearing aids, tissue engineering, medical components, orthopedics, prosthetics, dental, and others. Of these, the dental segment will command the largest share in the market over the forecast period. 

By end user, the digital 3D printing market is segmented into pharmaceutical and biotechnology companies, dental clinics and laboratories, hospitals and surgical centers, and others. Of these, hospitals and surgical centers will lead the market over the forecast period. 

Regional Analysis

By region, the global digital 3D printing market covers the growth opportunities and recent trends across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will command the largest share in the market over the forecast period for patients’ increased adoption of treatments, the rising incidence of diseases, and the presence of leading medical device companies in the region. The US is the key contributor in the region for increasing awareness, accessibility of advanced treatment options, developed healthcare infrastructure, and the presence of top market players. 

The digital 3D printing market in Europe is predicted to hold the second-largest share over the forecast period for the presence of developed economies like France, the UK, and Germany, increasing incidence of lifestyle-associated conditions, target population base, and favorable laws and government initiatives. 

The digital 3D printing market in the APAC region is predicted to grow at a high CAGR over the forecast period for the developing healthcare sector in Australia, India, Japan, and China, increasing prevalence of accidents, rising older population base, and growing per capita healthcare expenditure. 

The digital 3D printing market in the MEA is predicted to have a small share over the forecast period for extremely low-income and less economic developments in the African region. The market in the Middle East is predicted to have healthy growth over the forecast period. Saudi Arabia and Egypt are the key contributors in the region. 

Key Players

Leading players profiled in the global digital 3D printing market report include Renishaw PLC (UK), Micron Dental (US), General Electric (US), Materialise (Europe), ExOne (US), Formlabs (US), EnvisionTEC (US), Carbon, Inc. (US), 3D Systems, Inc. (US), and Stratasys Ltd (US). Industry players have incorporated key strategies such as product approvals, alliances, collaborations, mergers, partnerships, product launches, expansions, and acquisitions to stay ahead in the competition.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/digital-3d-printing-market-8680